Ramin Pirouz, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 985 Prince Frederick Blvd, Suite 201, Prince Frederick, MD 20678 Phone: 410-535-2005 Fax: 410-535-4850 |
Dr. Riffat Meraj, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1015 Prince Frederick Blvd., Prince Frederick, MD 20678 Phone: 410-535-4116 Fax: 410-414-8480 |
Dr. Peter L Wisniewski, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 985 Prince Frederick Blvd Ste 201, Prince Frederick, MD 20678 Phone: 410-535-2005 Fax: 410-535-4850 |
News Archive
On the final day of the International AIDS Conference-AIDS 2010 Friday, Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria called upon "China, India and other fast-growing economies" to chip in to help close the funding gap in efforts to battle HIV/AIDS, Agence France-Presse reports. "Until now, these countries have been recipients of AIDS funds, not donors," the news service writes.
The COPD Foundation (COPDF) announces today the launch of its COPD Pocket Consultant Guide (PCG) iPhone app, a practical tool designed to facilitate easier, more effective diagnosis and therapy for Chronic Obstructive Pulmonary Disease (COPD) during daily clinical care.
An artificial intelligence (AI) program can spot signs of lung cancer on CT scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.
The efficacy of preimplantation genetic screening has been one of the most hotly disputed subjects in assisted reproduction over the past few years. The European Society of Human Reproduction and Embryology PGS Task Force has now shown, in its groundbreaking proof of principle study, that screening of polar bodies (small cells that are the by-product of egg development), is a reliable method to analyse the chromosomal status of an egg.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its selective histone deacetylase (HDAC) inhibitors will be featured in five posters and one oral presentation at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place December 8-11, 2012, in Atlanta, Georgia.
› Verified 4 days ago